Confluence Wealth Services, Inc. Dexcom Inc Transaction History

Confluence Wealth Services, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 31, 2024	BUY	$110.31 - $140.45 $42,248 - $53,792	383 Added 12.8%	3,375 $382,000
Q1 2024 Apr 22, 2024	BUY	$114.22 - $140.1 $341,746 - $419,179	2,992 New	2,992 $414,000
Q1 2022 Apr 26, 2022	SELL	$94.08 - $130.2 $21,826 - $30,206	-232 Closed	0 $0
Q4 2021 Feb 10, 2022	BUY	$129.87 - $162.82 $30,129 - $37,774	232 New	232 $124,000

1,014

351M

5.51M

5.6M

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $31.1B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

Get notified when there are updates to the investment portfolio of Confluence Wealth Services, Inc., based on Form 13F filings with the SEC.

Stay updated on Confluence Wealth Services, Inc. with notifications on news.